These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15054170)

  • 1. Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding.
    Zara F; Nappi RE; Brerra R; Migliavacca R; Maserati R; Spinillo A
    Sex Transm Infect; 2004 Apr; 80(2):108-12. PubMed ID: 15054170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions.
    Spinillo A; Debiaggi M; Zara F; Maserati R; Polatti F; De Santolo A
    BJOG; 2001 Jun; 108(6):634-41. PubMed ID: 11426900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV shedding in cervico-vaginal secretions in pregnant women.
    Gardella B; Roccio M; Maccabruni A; Mariani B; Panzeri L; Zara F; Spinillo A
    Curr HIV Res; 2011 Jul; 9(5):313-20. PubMed ID: 21916839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.
    Cummins JE; Christensen L; Lennox JL; Bush TJ; Wu Z; Malamud D; Evans-Strickfaden T; Siddig A; Caliendo AM; Hart CE; Dezzutti CS
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):788-95. PubMed ID: 16910835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding.
    Al-Harthi L; Kovacs A; Coombs RW; Reichelderfer PS; Wright DJ; Cohen MH; Cohn J; Cu-Uvin S; Watts H; Lewis S; Beckner S; Landay A;
    AIDS; 2001 Aug; 15(12):1535-43. PubMed ID: 11504986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.
    Spinillo A; Debiaggi M; Zara F; De Santolo A; Polatti F; Filice G
    Obstet Gynecol; 2001 Jun; 97(6):999-1004. PubMed ID: 11384710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.
    Graham SM; Holte SE; Peshu NM; Richardson BA; Panteleeff DD; Jaoko WG; Ndinya-Achola JO; Mandaliya KN; Overbaugh JM; McClelland RS
    AIDS; 2007 Feb; 21(4):501-7. PubMed ID: 17301569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shedding of HIV-1 subtype E in semen and cervico-vaginal fluid.
    Sutthent R; Chaisilwattana P; Roongpisuthipong A; Wirachsilp P; Samrangsarp K; Chaiyakul P; Puthavathana P; Wasi C
    J Med Assoc Thai; 1997 Jun; 80(6):348-57. PubMed ID: 9240008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.
    Spinillo A; Zara F; Gardella B; Preti E; Mainini R; Maserati R
    Am J Obstet Gynecol; 2005 Mar; 192(3):774-9. PubMed ID: 15746671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood.
    García-Bujalance S; Ruiz G; De Guevara CL; Peña JM; Bates I; Vázquez JJ; Gutiérrez A
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):111-5. PubMed ID: 14735402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.
    Ondoa P; Gautam R; Rusine J; Lutter R; Jurriaans S; Kootstra N; Karita E; van de Wijgert J
    PLoS One; 2015; 10(5):e0127201. PubMed ID: 26010956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
    Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of non-nucleoside reverse transcriptase inhibitors on cytokine, chemokine, and immunoglobulin profiles in serum and genital secretions of HIV-infected women.
    Sachdeva RK; Wanchu A; Bagga R; Malla N; Sharma M
    J Interferon Cytokine Res; 2010 May; 30(5):299-310. PubMed ID: 20187769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital Shedding of Human Immunodeficiency Virus Type-1 (HIV) When Antiretroviral Therapy Suppresses HIV Replication in the Plasma.
    Bull M; Mitchell C; Soria J; Styrchak S; Williams C; Dragavon J; Ryan KJ; Acosta E; Onchiri F; Coombs RW; La Rosa A; Ticona E; Frenkel LM
    J Infect Dis; 2020 Aug; 222(5):777-786. PubMed ID: 32274499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between vaginal bacteria implicated in HIV acquisition risk and proinflammatory cytokines and chemokines.
    Sabo MC; Lehman DA; Wang B; Richardson BA; Srinivasan S; Osborn L; Matemo D; Kinuthia J; Fiedler TL; Munch MM; Drake AL; Fredricks DN; Overbaugh J; John-Stewart G; McClelland RS; Graham SM
    Sex Transm Infect; 2020 Feb; 96(1):3-9. PubMed ID: 31197065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical intraepithelial neoplasia and cervicovaginal shedding of human immunodeficiency virus.
    Spinillo A; Zara F; Gardella B; Preti E; Gaia G; Maserati R
    Obstet Gynecol; 2006 Feb; 107(2 Pt 1):314-20. PubMed ID: 16449118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.